Short- and Medium-Term Surgical Outcomes of Tissue-Engineered Pulmonary Valve Replacement in Sheep.

However, the CELL group showed a trend toward reduced thoracic drainage (Table 1 ), and an absence of pleural or pericardial effusions, ascites, and endocarditis (Table 3 ), likely due to the immunomodulatory and anti-inflammatory properties of ADSCs.

also in 53,322 other papers